Automated Suturing Devices Market 2018 | Reaches To USD 4.50 Billion Registering A CAGR of ~7.2% | by 2023; Asserts MRFR

MarketResearchFuture.com adds “Automated Suturing Devices Market -2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

Regional analysis:
Globally, North America accounts for the largest market share in automated suturing devices. This is attributed to the replacement of manual suturing using needles by automated suturing devices. The demand for disposable suturing devices has outreached reusable suturing devices due to growing emphasis on hospital acquired infection and to reduce surgical site infection. Patients with surgical site infection require long recovery period thus increasing patient’s stay in the hospital. This may affect bed occupancy rate of hospitals thus increasing the chances of hospital acquired infection to the patient. Thus, preventions of infection is a major objective behind using disposable automated suturing devices. The market in America is also influenced by increasing number of surgical procedures performed thus requiring safe closure of surgical site.

Key Players in the Automated Suturing Devices market:
Key players in the automated devices market are Ethicon Inc. (Subsidiary of Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc. (Ireland), DemeTECH Corporation (U.S.),  Smith & Nephew plc (U.K.), Péters Surgical (France), EndoEvolution LLC (U.S.),  Boston Scientific Corporation (U.S.) and Sutures India Pvt. Ltd. (India). The main focus of these players is tapping the market in developing regions across the globe.

Automated Suturing Devices market-Overview:
Sutures are sterile surgical instruments used for the closure of surgical incision or wound. Sutures are either automated or manually operated devices. Demand for automated suturing devices is increasing due to an increase in the number of surgeries performed in the hospital, demand of safe closure of surgical site, prevention of hospital acquired infection, and improved quality of healthcare.

There is an increasing demand for automated suturing devices in the market owing to an increasing number of surgical procedures in hospitals and rising prevalence of chronic diseases. The market is further stimulated by a technology advancement in surgical devices having applications in various fields of medicine such as dentistry, gynaecology, cardiology, urology, and others.

Segmentation:
Global Automated suturing devices market has been segmented on the basis of type of suturing device which includes disposable and reusable suturing devices. On the basis of application the market is segmented into Cardiac, Orthopedic, Ophthalmic, Dental, Gynecological and other applications. End users are hospitals, clinics and other users.

TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1207 .

Key developments:
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

Ethicon Inc.:

Ethicon Inc. is a subsidiary of Johnson & Johnson, manufacturing surgical sutures and wound closure devices. Enseal X1 is a suturing devices designed for use in open surgical procedures. Harmonic HD 1000 is designed of laparoscopic surgery.

• February 2017: Ethicon, Inc. today announced an agreement to acquire Torax Medical, Inc., a private medical device company manufacturing and marketing the LINX Reflux Management System, a novel minimally invasive device for the surgical treatment of GERD. This acquisition will enable the company to offer patients effective alternative to the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. LINX Reflux Management System comprises of interlinked titanium beads with magnetic cores. LINX is currently used by physicians in over 300 hospitals in the U.S. and Europe. This acquisition is a part of strategic approach advancement in innovation and investment in esophageal health.

1. Braun Melsungen AG:
2. Braun Melsungen AG is a medical and pharmaceutical device company.

• Safil parenchyma Set, Securex, Securex are special suture sets offered by the company.
• April 2017: B. Braun Melsungen AG announced the launch of new home infusion therapy application that will help healthcare professionals and patients. This app allows infusion therapy nurses to educate the patients to use Easypump at their own homes.
• October, 2015: B. Braun Medical Inc., announced that it will the launch its latest advancement in echogenic peripheral nerve block needle technology at American Society of Anesthesiologists (ASA) Annual Meeting at the San Diego Convention Center. The product “Stimuplex Ultra 360” denotes a key advancement in regional anesthesia.

Medtronic plc.:
Founded in 1949, Medtronic plc is a global healthcare solutions company committed to improving the lives of people through their medical technologies, services, and solutions.

• October, 2016: Medtronics plc. Received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.
• December, 2015: Medtronic plc. and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.

Boston Scientific Corporation:
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, electrophysiology, cardiac surgery, oncology, urology and others.

• October, 2017: Boston Scientific Corporation announced an agreement to acquire Apama Medical Inc., a privately-held company, developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). Through this acuquistion the company desires to invest in the electrophysiology category and to expand the product portfolio of differentiated arrhythmia solutions.

…CONTINUED

AVAIL DISCOUNT REPORT @ https://www.marketresearchfuture.com/check-discount/1207 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, 
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com